NBOCC Clinical Best Practice
www.nbocc.com.au

Clinical Best Practice Home  ›  Early breast cancer

Early breast cancer

Clinical Practice Guidelines for the Management of Early Breast Cancer

August 2001

Clinical practice guidelines for the management of early breast cancer aims to be a document useful for both health professionals and consumers. It is designed to:

  • Assist in decision-making by women and their doctors;
  • Educate all involved in the care of women with breast cancer;
  • Assess and assure the quality of care;
  • Reduce the risk of legal liability by improving care; and
  • Bring the issue of cost-effectiveness into the public arena.
  • This book presents guidelines, and does not pretend to be a textbook. Clinicians looking for further information on the biology and natural history of breast cancer should consult the relevant texts.

The guidelines are not rigid procedural paths, nor are they prescriptive. They aim to provide information on which decisions can be made, rather than dictate what the decisions should be.

The guidelines are designed to provide information to assist decision making and are based on the best evidence available at time of publication. They are a guide to appropriate practice, to be followed subject to the clinician’s judgement and the woman’s preference in each individual case.

This is the second edition of the Clinical practice guidelines for the management of early breast cancer and replaces the first edition released in 1995.

 

Topic specific guideline updates

July 2008

As new evidence becomes available, NBOCC develops topic-specific updates on priority guideline topics as supplements to the Clinical practice guidelines for early breast cancer.

Current guideline updates available for early breast cancer are:



NBOCC resources

Clinical Practice Guidelines For The Management Of Early Breast Cancer.

View PDF of resource View pdf (719 kb)

Order from NBOCC › Order from NBOCC
Please also see supplement to these guidelines below:

Recommendations for Aromatase inhibitors as adjuvant endocrine therapy

View PDF of resourceView pdf (328 kb)

Order from NBOCCOrder from NBOCC

Recommendations for use of sentinel node biopsy in early (operable) breast cancer

View PDF of resourceView pdf
Order from NBOCCOrder from NBOCC

Recommendations for use of taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer

View PDF of resourceView pdf
Order from NBOCCOrder from NBOCC

Recommendations for use of Trastuzumab (Herceptin®) for the treatment of HER2-positive breast cancer

View PDF of resourceView pdf
Order from NBOCCOrder from NBOCC

The use of intraoperative radiotherapy - for the treatment of patients with early breast cancer
View PDF of resource View pdf (107 kb)

Order from NBOCCOrder from NBOCC

Other NBOCC resources »

Tell us more »

Was this site useful/helpful?

very 

quite 

uncertain 

not

Did you find the information you were looking for?

yes 

partly 

uncertain 

no

What were you looking for?

Back to top

National Breast and Ovarian Cancer Centre | breasthealth | Clinical Best Practice | Ovarian Cancer